Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signaling pathways are complex, coordinated series of molecular interactions and chemical reactions that allow cells to perceive and respond to internal and external stimuli (1). These pathways generally begin with the activation of a sensor, such as a cell-surface receptor, which then triggers a cascade of downstream events often involving protein phosphorylation, second messengers, and the activation of transcription factors (2). The primary biological function of these networks is to regulate critical cellular processes, including growth, metabolism, and programmed cell death (3). Dysregulation of signaling pathways is a fundamental driver of many diseases; for example, hyperactivation of the PI3K/Akt/mTOR or MAPK pathways is frequently observed in various cancers (1, 3). In drug discovery, specific components of these pathways, such as tyrosine kinases or G protein-coupled receptors, serve as primary therapeutic targets (2). Because "Signaling pathways" is a broad, collective term rather than a single druggable molecule, it is classified as an incorrect entry for a specific therapeutic target database (1). Understanding the architecture of these pathways is essential for developing precision medicines that can bypass resistance mechanisms or mitigate off-target toxicities (3). Sources: 1. National Human Genome Research Institute (NHGRI). "Signaling Pathway." genome.gov. 2. Nature Education. "Cell Signaling." nature.com/scitable. 3. StatPearls [Internet]. "Signal Transduction." Treasure Island (FL): StatPearls Publishing; 2023.
Pharmacological agents typically modulate signaling pathways by acting as agonists or antagonists to specific molecular components, such as receptors, kinases, or transcription factors, rather than targeting the pathway as a collective entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signaling pathways.